Dr. Reddy's Receives Brazilian Regulatory Approval for Generic Ozempic

Dr. Reddy’s Laboratories received approval from Brazilian health authorities to market a generic version of Ozempic, expanding its product portfolio in Brazil. The company said the approval supports its strategy of offering affordable treatments for chronic diseases. The article did not report financial figures or a stock-price impact.